Malignant lymphoma with peripheral neuropathy

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

10 events
Mar 2026TAFINLAR: New indication approved
FDAcompleted
Mar 2026TAFINLAR: New indication approved
FDAcompleted
Feb 2026Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia

The Hong Kong Polytechnic University — NA

TrialNOT YET RECRUITING
Apr 2025TAFINLAR: New indication approved
FDAcompleted
Apr 2025TAFINLAR: New indication approved
FDAcompleted
Mar 2025TAFINLAR: New indication approved
FDAcompleted
Mar 2025TAFINLAR: New indication approved
FDAcompleted
Mar 2025TAFINLAR: New indication approved
FDAcompleted
Mar 2025TAFINLAR: New indication approved
FDAcompleted
Jan 2025TAFINLAR: New indication approved
FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

TAFINLAR

Novartis Pharmaceuticals Corp.

OpenContact for detailsApply ↗

View all support programs on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Malignant lymphoma with peripheral neuropathy.
Search all trials →
Search clinical trials for Malignant lymphoma with peripheral neuropathy

Recent News & Research

No recent news articles indexed yet for Malignant lymphoma with peripheral neuropathy.
Search PubMed for Malignant lymphoma with peripheral neuropathy

Browse all Malignant lymphoma with peripheral neuropathy news →

Specialist Network

Top 6 by expertise

View all Malignant lymphoma with peripheral neuropathy specialists →

Quick Actions